Arbutus Biopharma CorporationABUSNASDAQ
LOADING
|||
EBITDA Over Time
Above historical average.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-68.40M
↑ 44% above average
Average (9y)
$-122.31M
Historical baseline
Range
High:$-57.76M
Low:$-488.07M
CAGR
-1.3%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-68.40M | +3.6% |
| 2023 | $-70.99M | -14.8% |
| 2022 | $-61.86M | +13.6% |
| 2021 | $-71.64M | -24.0% |
| 2020 | $-57.76M | +64.4% |
| 2019 | $-162.24M | -175.2% |
| 2018 | $-58.95M | +44.6% |
| 2017 | $-106.44M | +78.2% |
| 2016 | $-488.07M | -536.2% |
| 2015 | $-76.72M | - |